Abstract
Alzheimer’s Disease (AD) is a traditional neurodegeneration disease in the world. In 1906, this disease is first described by German Neuroscientist, Alois Alzheimer, and it is named by this scientist, ‘Alzheimer’. Although 4-5% of patient carry AD at middle age, which is the Early- onset Alzheimer’s Disease. Normally, the average onset age of AD is above 65. The symptom of AD including dementia, loss of memory, cognitive impairment and eventually it will accelerate the death of aged people. There are two pathological factors that cause people have AD’s symptom: Amyloid Plaques and Neurofibrillary Tangles (NFTs). Focus on that, this review will mainly introduce two medicine treatments that target those two factors: The classical cholinergic medicine Donepezil and The Novel Lithium medicine that has been proved to treat AD since 2012. This article will describe the pathology of AD briefly; focus on those two medicines, the functional mechanism, effectiveness to AD and limitation will be described also.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
